nodes	percent_of_prediction	percent_of_DWPC	metapath
Silodosin—ADRA1B—Phendimetrazine—obesity	0.171	0.267	CbGbCtD
Silodosin—ADRA1A—Phendimetrazine—obesity	0.135	0.211	CbGbCtD
Silodosin—ADRA1A—Benzphetamine—obesity	0.102	0.16	CbGbCtD
Silodosin—ADRA1A—Phenylpropanolamine—obesity	0.0976	0.153	CbGbCtD
Silodosin—CYP3A4—Sibutramine—obesity	0.0298	0.0465	CbGbCtD
Silodosin—ABCB4—bile—obesity	0.0269	0.449	CbGeAlD
Silodosin—ABCB1—Cimetidine—obesity	0.0235	0.0367	CbGbCtD
Silodosin—CYP3A4—Benzphetamine—obesity	0.0226	0.0353	CbGbCtD
Silodosin—CYP3A4—Bupropion—obesity	0.0192	0.03	CbGbCtD
Silodosin—CYP3A4—Orlistat—obesity	0.0156	0.0244	CbGbCtD
Silodosin—CYP3A4—Cimetidine—obesity	0.0141	0.022	CbGbCtD
Silodosin—CYP3A4—Topiramate—obesity	0.00922	0.0144	CbGbCtD
Silodosin—ABCB4—gall bladder—obesity	0.00747	0.125	CbGeAlD
Silodosin—ABCB4—adrenal cortex—obesity	0.00388	0.0647	CbGeAlD
Silodosin—Swollen tongue—Bupropion—obesity	0.0036	0.0279	CcSEcCtD
Silodosin—ABCB4—adrenal gland—obesity	0.0028	0.0467	CbGeAlD
Silodosin—ABCB4—endocrine gland—obesity	0.00243	0.0405	CbGeAlD
Silodosin—Pharyngeal oedema—Topiramate—obesity	0.00236	0.0183	CcSEcCtD
Silodosin—Swelling face—Bupropion—obesity	0.00222	0.0172	CcSEcCtD
Silodosin—Erectile dysfunction—Methamphetamine—obesity	0.0022	0.0171	CcSEcCtD
Silodosin—ABCB4—liver—obesity	0.00219	0.0365	CbGeAlD
Silodosin—ADRA1A—hindbrain—obesity	0.00176	0.0294	CbGeAlD
Silodosin—Erectile dysfunction—Phentermine—obesity	0.00158	0.0123	CcSEcCtD
Silodosin—UGT2B7—digestive system—obesity	0.0015	0.0251	CbGeAlD
Silodosin—Palpitations—Methamphetamine—obesity	0.00147	0.0114	CcSEcCtD
Silodosin—Palpitations—Benzphetamine—obesity	0.00142	0.011	CcSEcCtD
Silodosin—Swelling face—Topiramate—obesity	0.00141	0.011	CcSEcCtD
Silodosin—Erectile dysfunction—Diethylpropion—obesity	0.00138	0.0107	CcSEcCtD
Silodosin—Tachycardia—Methamphetamine—obesity	0.00133	0.0103	CcSEcCtD
Silodosin—Erectile dysfunction—Cimetidine—obesity	0.00131	0.0102	CcSEcCtD
Silodosin—Rhinorrhoea—Bupropion—obesity	0.0013	0.0101	CcSEcCtD
Silodosin—Palpitations—Phendimetrazine—obesity	0.0013	0.0101	CcSEcCtD
Silodosin—Tachycardia—Benzphetamine—obesity	0.00128	0.00995	CcSEcCtD
Silodosin—UGT2B7—endocrine gland—obesity	0.00124	0.0207	CbGeAlD
Silodosin—Insomnia—Methamphetamine—obesity	0.00123	0.00956	CcSEcCtD
Silodosin—Insomnia—Benzphetamine—obesity	0.00119	0.00922	CcSEcCtD
Silodosin—Gastrointestinal disorder—Methamphetamine—obesity	0.00118	0.00913	CcSEcCtD
Silodosin—Tachycardia—Phendimetrazine—obesity	0.00117	0.00907	CcSEcCtD
Silodosin—Gastrointestinal disorder—Benzphetamine—obesity	0.00113	0.0088	CcSEcCtD
Silodosin—UGT2B7—liver—obesity	0.00112	0.0187	CbGeAlD
Silodosin—Insomnia—Phendimetrazine—obesity	0.00108	0.0084	CcSEcCtD
Silodosin—Urticaria—Methamphetamine—obesity	0.00108	0.0084	CcSEcCtD
Silodosin—Palpitations—Phentermine—obesity	0.00106	0.00822	CcSEcCtD
Silodosin—Urticaria—Benzphetamine—obesity	0.00104	0.0081	CcSEcCtD
Silodosin—Hepatic function abnormal—Sibutramine—obesity	0.00101	0.00782	CcSEcCtD
Silodosin—Dry mouth—Phentermine—obesity	0.000998	0.00775	CcSEcCtD
Silodosin—Tachycardia—Phenylpropanolamine—obesity	0.000997	0.00775	CcSEcCtD
Silodosin—ADRA1D—endocrine gland—obesity	0.000986	0.0164	CbGeAlD
Silodosin—Vascular purpura—Sibutramine—obesity	0.000984	0.00764	CcSEcCtD
Silodosin—Nasal congestion—Sibutramine—obesity	0.000966	0.0075	CcSEcCtD
Silodosin—Hypotension—Phenylpropanolamine—obesity	0.000955	0.00742	CcSEcCtD
Silodosin—Tachycardia—Phentermine—obesity	0.000954	0.00741	CcSEcCtD
Silodosin—Libido decreased—Sibutramine—obesity	0.000949	0.00737	CcSEcCtD
Silodosin—Abdominal pain—Phendimetrazine—obesity	0.000946	0.00734	CcSEcCtD
Silodosin—Tamsulosin—DRD2—obesity	0.000939	1	CrCbGaD
Silodosin—Diarrhoea—Methamphetamine—obesity	0.000931	0.00723	CcSEcCtD
Silodosin—Insomnia—Phenylpropanolamine—obesity	0.000924	0.00718	CcSEcCtD
Silodosin—Palpitations—Diethylpropion—obesity	0.000921	0.00715	CcSEcCtD
Silodosin—Purpura—Sibutramine—obesity	0.000913	0.00709	CcSEcCtD
Silodosin—Dizziness—Methamphetamine—obesity	0.0009	0.00699	CcSEcCtD
Silodosin—Diarrhoea—Benzphetamine—obesity	0.000898	0.00697	CcSEcCtD
Silodosin—Insomnia—Phentermine—obesity	0.000884	0.00687	CcSEcCtD
Silodosin—Hepatic function abnormal—Bupropion—obesity	0.000878	0.00682	CcSEcCtD
Silodosin—Disturbance in sexual arousal—Sibutramine—obesity	0.000873	0.00678	CcSEcCtD
Silodosin—Dizziness—Benzphetamine—obesity	0.000868	0.00674	CcSEcCtD
Silodosin—Dry mouth—Diethylpropion—obesity	0.000868	0.00674	CcSEcCtD
Silodosin—Headache—Methamphetamine—obesity	0.000853	0.00662	CcSEcCtD
Silodosin—Gastrointestinal disorder—Phentermine—obesity	0.000844	0.00656	CcSEcCtD
Silodosin—Nasal congestion—Bupropion—obesity	0.000842	0.00654	CcSEcCtD
Silodosin—Rhinorrhoea—Topiramate—obesity	0.000831	0.00645	CcSEcCtD
Silodosin—Tachycardia—Diethylpropion—obesity	0.00083	0.00645	CcSEcCtD
Silodosin—Libido decreased—Bupropion—obesity	0.000827	0.00642	CcSEcCtD
Silodosin—ADRA1A—cardiovascular system—obesity	0.000825	0.0138	CbGeAlD
Silodosin—Headache—Benzphetamine—obesity	0.000822	0.00639	CcSEcCtD
Silodosin—Breast disorder—Orlistat—obesity	0.000822	0.00638	CcSEcCtD
Silodosin—Diarrhoea—Phendimetrazine—obesity	0.000818	0.00636	CcSEcCtD
Silodosin—Liver function test abnormal—Sibutramine—obesity	0.000812	0.00631	CcSEcCtD
Silodosin—Orthostatic hypotension—Sibutramine—obesity	0.000804	0.00624	CcSEcCtD
Silodosin—Dizziness—Phendimetrazine—obesity	0.000791	0.00614	CcSEcCtD
Silodosin—Tachycardia—Cimetidine—obesity	0.00079	0.00614	CcSEcCtD
Silodosin—Nausea—Benzphetamine—obesity	0.00078	0.00605	CcSEcCtD
Silodosin—Urticaria—Phentermine—obesity	0.000777	0.00603	CcSEcCtD
Silodosin—Abdominal pain—Phentermine—obesity	0.000773	0.006	CcSEcCtD
Silodosin—Insomnia—Diethylpropion—obesity	0.000769	0.00598	CcSEcCtD
Silodosin—Disturbance in sexual arousal—Bupropion—obesity	0.000761	0.00591	CcSEcCtD
Silodosin—Headache—Phendimetrazine—obesity	0.000749	0.00582	CcSEcCtD
Silodosin—Gastrointestinal disorder—Diethylpropion—obesity	0.000734	0.0057	CcSEcCtD
Silodosin—ADRA1A—adipose tissue—obesity	0.000728	0.0121	CbGeAlD
Silodosin—Nausea—Phendimetrazine—obesity	0.000711	0.00552	CcSEcCtD
Silodosin—Asthenia—Phentermine—obesity	0.000702	0.00545	CcSEcCtD
Silodosin—Orthostatic hypotension—Bupropion—obesity	0.000701	0.00544	CcSEcCtD
Silodosin—Erectile dysfunction—Sibutramine—obesity	0.0007	0.00544	CcSEcCtD
Silodosin—Breast disorder—Bupropion—obesity	0.000693	0.00538	CcSEcCtD
Silodosin—Nasopharyngitis—Bupropion—obesity	0.000686	0.00533	CcSEcCtD
Silodosin—Urticaria—Diethylpropion—obesity	0.000676	0.00525	CcSEcCtD
Silodosin—Dizziness—Phenylpropanolamine—obesity	0.000676	0.00525	CcSEcCtD
Silodosin—Diarrhoea—Phentermine—obesity	0.000669	0.0052	CcSEcCtD
Silodosin—Hepatobiliary disease—Orlistat—obesity	0.000663	0.00515	CcSEcCtD
Silodosin—Sinusitis—Orlistat—obesity	0.000657	0.00511	CcSEcCtD
Silodosin—ADRA1A—adrenal gland—obesity	0.000653	0.0109	CbGeAlD
Silodosin—Dizziness—Phentermine—obesity	0.000647	0.00502	CcSEcCtD
Silodosin—Rash—Phenylpropanolamine—obesity	0.000644	0.005	CcSEcCtD
Silodosin—Dermatitis—Phenylpropanolamine—obesity	0.000644	0.005	CcSEcCtD
Silodosin—Sinusitis—Sibutramine—obesity	0.000636	0.00494	CcSEcCtD
Silodosin—Rash—Phentermine—obesity	0.000617	0.00479	CcSEcCtD
Silodosin—Dermatitis—Phentermine—obesity	0.000616	0.00478	CcSEcCtD
Silodosin—Headache—Phentermine—obesity	0.000613	0.00476	CcSEcCtD
Silodosin—Erectile dysfunction—Bupropion—obesity	0.000611	0.00474	CcSEcCtD
Silodosin—Nausea—Phenylpropanolamine—obesity	0.000607	0.00471	CcSEcCtD
Silodosin—Diarrhoea—Diethylpropion—obesity	0.000582	0.00452	CcSEcCtD
Silodosin—Nausea—Phentermine—obesity	0.000581	0.00451	CcSEcCtD
Silodosin—Asthenia—Cimetidine—obesity	0.000581	0.00451	CcSEcCtD
Silodosin—Jaundice—Bupropion—obesity	0.000576	0.00448	CcSEcCtD
Silodosin—Immune system disorder—Orlistat—obesity	0.000568	0.00441	CcSEcCtD
Silodosin—Mediastinal disorder—Orlistat—obesity	0.000567	0.0044	CcSEcCtD
Silodosin—ADRA1A—endocrine gland—obesity	0.000566	0.00944	CbGeAlD
Silodosin—Dizziness—Diethylpropion—obesity	0.000563	0.00437	CcSEcCtD
Silodosin—Sinusitis—Bupropion—obesity	0.000555	0.00431	CcSEcCtD
Silodosin—Diarrhoea—Cimetidine—obesity	0.000554	0.0043	CcSEcCtD
Silodosin—Angiopathy—Sibutramine—obesity	0.000552	0.00429	CcSEcCtD
Silodosin—Mental disorder—Orlistat—obesity	0.000551	0.00428	CcSEcCtD
Silodosin—Immune system disorder—Sibutramine—obesity	0.00055	0.00427	CcSEcCtD
Silodosin—Vascular purpura—Topiramate—obesity	0.000546	0.00424	CcSEcCtD
Silodosin—Nasal congestion—Topiramate—obesity	0.000536	0.00417	CcSEcCtD
Silodosin—Rash—Diethylpropion—obesity	0.000536	0.00417	CcSEcCtD
Silodosin—Dermatitis—Diethylpropion—obesity	0.000536	0.00416	CcSEcCtD
Silodosin—Dizziness—Cimetidine—obesity	0.000535	0.00416	CcSEcCtD
Silodosin—Headache—Diethylpropion—obesity	0.000533	0.00414	CcSEcCtD
Silodosin—Libido decreased—Topiramate—obesity	0.000527	0.00409	CcSEcCtD
Silodosin—ADRA1A—liver—obesity	0.00051	0.00851	CbGeAlD
Silodosin—Rash—Cimetidine—obesity	0.00051	0.00396	CcSEcCtD
Silodosin—Dermatitis—Cimetidine—obesity	0.00051	0.00396	CcSEcCtD
Silodosin—Headache—Cimetidine—obesity	0.000507	0.00394	CcSEcCtD
Silodosin—Purpura—Topiramate—obesity	0.000507	0.00394	CcSEcCtD
Silodosin—Nausea—Diethylpropion—obesity	0.000505	0.00392	CcSEcCtD
Silodosin—Cardiac disorder—Bupropion—obesity	0.000493	0.00383	CcSEcCtD
Silodosin—Disturbance in sexual arousal—Topiramate—obesity	0.000485	0.00377	CcSEcCtD
Silodosin—Palpitations—Orlistat—obesity	0.000484	0.00376	CcSEcCtD
Silodosin—ABCB1—islet of Langerhans—obesity	0.000483	0.00807	CbGeAlD
Silodosin—Angiopathy—Bupropion—obesity	0.000481	0.00374	CcSEcCtD
Silodosin—Nausea—Cimetidine—obesity	0.000481	0.00373	CcSEcCtD
Silodosin—Immune system disorder—Bupropion—obesity	0.000479	0.00372	CcSEcCtD
Silodosin—Mediastinal disorder—Bupropion—obesity	0.000478	0.00371	CcSEcCtD
Silodosin—Syncope—Sibutramine—obesity	0.000475	0.00369	CcSEcCtD
Silodosin—Palpitations—Sibutramine—obesity	0.000468	0.00364	CcSEcCtD
Silodosin—Loss of consciousness—Sibutramine—obesity	0.000466	0.00362	CcSEcCtD
Silodosin—Mental disorder—Bupropion—obesity	0.000465	0.00361	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000463	0.0036	CcSEcCtD
Silodosin—ABCB1—respiratory system—obesity	0.000457	0.00762	CbGeAlD
Silodosin—Dry mouth—Orlistat—obesity	0.000456	0.00354	CcSEcCtD
Silodosin—Liver function test abnormal—Topiramate—obesity	0.000451	0.0035	CcSEcCtD
Silodosin—Orthostatic hypotension—Topiramate—obesity	0.000446	0.00347	CcSEcCtD
Silodosin—Breast disorder—Topiramate—obesity	0.000442	0.00343	CcSEcCtD
Silodosin—Dry mouth—Sibutramine—obesity	0.000441	0.00343	CcSEcCtD
Silodosin—Nervous system disorder—Orlistat—obesity	0.000438	0.0034	CcSEcCtD
Silodosin—Nasopharyngitis—Topiramate—obesity	0.000437	0.00339	CcSEcCtD
Silodosin—Skin disorder—Orlistat—obesity	0.000434	0.00337	CcSEcCtD
Silodosin—Shock—Sibutramine—obesity	0.000425	0.0033	CcSEcCtD
Silodosin—Tachycardia—Sibutramine—obesity	0.000422	0.00328	CcSEcCtD
Silodosin—Skin disorder—Sibutramine—obesity	0.00042	0.00326	CcSEcCtD
Silodosin—Syncope—Bupropion—obesity	0.000414	0.00322	CcSEcCtD
Silodosin—CYP3A4—digestive system—obesity	0.00041	0.00684	CbGeAlD
Silodosin—Palpitations—Bupropion—obesity	0.000408	0.00317	CcSEcCtD
Silodosin—Loss of consciousness—Bupropion—obesity	0.000406	0.00315	CcSEcCtD
Silodosin—Insomnia—Orlistat—obesity	0.000404	0.00314	CcSEcCtD
Silodosin—Hypotension—Sibutramine—obesity	0.000404	0.00314	CcSEcCtD
Silodosin—Insomnia—Sibutramine—obesity	0.000391	0.00304	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000391	0.00303	CcSEcCtD
Silodosin—Erectile dysfunction—Topiramate—obesity	0.000389	0.00302	CcSEcCtD
Silodosin—Gastrointestinal disorder—Orlistat—obesity	0.000386	0.003	CcSEcCtD
Silodosin—Dry mouth—Bupropion—obesity	0.000385	0.00299	CcSEcCtD
Silodosin—ABCB1—adrenal cortex—obesity	0.000383	0.00639	CbGeAlD
Silodosin—Gastrointestinal disorder—Sibutramine—obesity	0.000373	0.0029	CcSEcCtD
Silodosin—Shock—Bupropion—obesity	0.000371	0.00288	CcSEcCtD
Silodosin—Nervous system disorder—Bupropion—obesity	0.00037	0.00287	CcSEcCtD
Silodosin—Tachycardia—Bupropion—obesity	0.000368	0.00286	CcSEcCtD
Silodosin—Skin disorder—Bupropion—obesity	0.000366	0.00284	CcSEcCtD
Silodosin—Gastrointestinal pain—Orlistat—obesity	0.000365	0.00284	CcSEcCtD
Silodosin—Urticaria—Orlistat—obesity	0.000355	0.00276	CcSEcCtD
Silodosin—Gastrointestinal pain—Sibutramine—obesity	0.000354	0.00275	CcSEcCtD
Silodosin—Sinusitis—Topiramate—obesity	0.000353	0.00274	CcSEcCtD
Silodosin—Abdominal pain—Orlistat—obesity	0.000353	0.00274	CcSEcCtD
Silodosin—Hypotension—Bupropion—obesity	0.000352	0.00274	CcSEcCtD
Silodosin—ABCB1—cardiovascular system—obesity	0.00035	0.00583	CbGeAlD
Silodosin—Urticaria—Sibutramine—obesity	0.000344	0.00267	CcSEcCtD
Silodosin—Abdominal pain—Sibutramine—obesity	0.000342	0.00266	CcSEcCtD
Silodosin—Insomnia—Bupropion—obesity	0.000341	0.00265	CcSEcCtD
Silodosin—CYP3A4—endocrine gland—obesity	0.000339	0.00565	CbGeAlD
Silodosin—Gastrointestinal disorder—Bupropion—obesity	0.000325	0.00253	CcSEcCtD
Silodosin—Asthenia—Orlistat—obesity	0.000321	0.00249	CcSEcCtD
Silodosin—Pruritus—Orlistat—obesity	0.000316	0.00246	CcSEcCtD
Silodosin—Cardiac disorder—Topiramate—obesity	0.000314	0.00244	CcSEcCtD
Silodosin—Asthenia—Sibutramine—obesity	0.00031	0.00241	CcSEcCtD
Silodosin—ABCB1—pituitary gland—obesity	0.00031	0.00516	CbGeAlD
Silodosin—ABCB1—adipose tissue—obesity	0.000308	0.00514	CbGeAlD
Silodosin—Gastrointestinal pain—Bupropion—obesity	0.000308	0.00239	CcSEcCtD
Silodosin—Angiopathy—Topiramate—obesity	0.000307	0.00238	CcSEcCtD
Silodosin—Pruritus—Sibutramine—obesity	0.000306	0.00238	CcSEcCtD
Silodosin—Diarrhoea—Orlistat—obesity	0.000306	0.00237	CcSEcCtD
Silodosin—CYP3A4—liver—obesity	0.000305	0.0051	CbGeAlD
Silodosin—Immune system disorder—Topiramate—obesity	0.000305	0.00237	CcSEcCtD
Silodosin—Mediastinal disorder—Topiramate—obesity	0.000305	0.00237	CcSEcCtD
Silodosin—Urticaria—Bupropion—obesity	0.0003	0.00233	CcSEcCtD
Silodosin—Abdominal pain—Bupropion—obesity	0.000298	0.00231	CcSEcCtD
Silodosin—Mental disorder—Topiramate—obesity	0.000296	0.0023	CcSEcCtD
Silodosin—Diarrhoea—Sibutramine—obesity	0.000296	0.0023	CcSEcCtD
Silodosin—Dizziness—Orlistat—obesity	0.000296	0.0023	CcSEcCtD
Silodosin—ABCB1—digestive system—obesity	0.00029	0.00484	CbGeAlD
Silodosin—Dizziness—Sibutramine—obesity	0.000286	0.00222	CcSEcCtD
Silodosin—Rash—Orlistat—obesity	0.000282	0.00219	CcSEcCtD
Silodosin—Dermatitis—Orlistat—obesity	0.000281	0.00219	CcSEcCtD
Silodosin—Headache—Orlistat—obesity	0.00028	0.00217	CcSEcCtD
Silodosin—ABCB1—adrenal gland—obesity	0.000277	0.00461	CbGeAlD
Silodosin—Rash—Sibutramine—obesity	0.000273	0.00212	CcSEcCtD
Silodosin—Dermatitis—Sibutramine—obesity	0.000272	0.00212	CcSEcCtD
Silodosin—Headache—Sibutramine—obesity	0.000271	0.0021	CcSEcCtD
Silodosin—Asthenia—Bupropion—obesity	0.000271	0.0021	CcSEcCtD
Silodosin—Pruritus—Bupropion—obesity	0.000267	0.00207	CcSEcCtD
Silodosin—Nausea—Orlistat—obesity	0.000265	0.00206	CcSEcCtD
Silodosin—Syncope—Topiramate—obesity	0.000264	0.00205	CcSEcCtD
Silodosin—Palpitations—Topiramate—obesity	0.00026	0.00202	CcSEcCtD
Silodosin—Loss of consciousness—Topiramate—obesity	0.000259	0.00201	CcSEcCtD
Silodosin—Diarrhoea—Bupropion—obesity	0.000258	0.002	CcSEcCtD
Silodosin—Nausea—Sibutramine—obesity	0.000257	0.002	CcSEcCtD
Silodosin—Dizziness—Bupropion—obesity	0.000249	0.00194	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000249	0.00193	CcSEcCtD
Silodosin—Dry mouth—Topiramate—obesity	0.000245	0.0019	CcSEcCtD
Silodosin—ABCB1—endocrine gland—obesity	0.00024	0.004	CbGeAlD
Silodosin—Rash—Bupropion—obesity	0.000238	0.00185	CcSEcCtD
Silodosin—Dermatitis—Bupropion—obesity	0.000238	0.00184	CcSEcCtD
Silodosin—Shock—Topiramate—obesity	0.000236	0.00184	CcSEcCtD
Silodosin—Headache—Bupropion—obesity	0.000236	0.00183	CcSEcCtD
Silodosin—Nervous system disorder—Topiramate—obesity	0.000236	0.00183	CcSEcCtD
Silodosin—Tachycardia—Topiramate—obesity	0.000234	0.00182	CcSEcCtD
Silodosin—Skin disorder—Topiramate—obesity	0.000233	0.00181	CcSEcCtD
Silodosin—Hypotension—Topiramate—obesity	0.000224	0.00174	CcSEcCtD
Silodosin—Nausea—Bupropion—obesity	0.000224	0.00174	CcSEcCtD
Silodosin—Insomnia—Topiramate—obesity	0.000217	0.00169	CcSEcCtD
Silodosin—ABCB1—liver—obesity	0.000216	0.00361	CbGeAlD
Silodosin—Gastrointestinal disorder—Topiramate—obesity	0.000207	0.00161	CcSEcCtD
Silodosin—Gastrointestinal pain—Topiramate—obesity	0.000196	0.00153	CcSEcCtD
Silodosin—Urticaria—Topiramate—obesity	0.000191	0.00148	CcSEcCtD
Silodosin—Abdominal pain—Topiramate—obesity	0.00019	0.00147	CcSEcCtD
Silodosin—Asthenia—Topiramate—obesity	0.000172	0.00134	CcSEcCtD
Silodosin—Pruritus—Topiramate—obesity	0.00017	0.00132	CcSEcCtD
Silodosin—Diarrhoea—Topiramate—obesity	0.000164	0.00128	CcSEcCtD
Silodosin—Dizziness—Topiramate—obesity	0.000159	0.00123	CcSEcCtD
Silodosin—Rash—Topiramate—obesity	0.000151	0.00118	CcSEcCtD
Silodosin—Dermatitis—Topiramate—obesity	0.000151	0.00118	CcSEcCtD
Silodosin—Headache—Topiramate—obesity	0.00015	0.00117	CcSEcCtD
Silodosin—Nausea—Topiramate—obesity	0.000143	0.00111	CcSEcCtD
Silodosin—CYP3A4—Metabolism—ADH1B—obesity	6.22e-06	3.65e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—SREBF1—obesity	6.22e-06	3.65e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CAV1—obesity	6.2e-06	3.64e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—LPL—obesity	6.2e-06	3.64e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PIK3CD—obesity	6.2e-06	3.64e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—APOA1—obesity	6.19e-06	3.63e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SOCS3—obesity	6.18e-06	3.63e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—FOXO1—obesity	6.15e-06	3.61e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—RPS6KB1—obesity	6.14e-06	3.61e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ACSL1—obesity	6.12e-06	3.6e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GPAM—obesity	6.12e-06	3.6e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PPARGC1B—obesity	6.12e-06	3.6e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—PIK3CB—obesity	6.08e-06	3.57e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GOT2—obesity	6.05e-06	3.55e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—GNB3—obesity	6.05e-06	3.55e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—ESR1—obesity	5.98e-06	3.51e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—TYK2—obesity	5.96e-06	3.5e-05	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—PIK3CB—obesity	5.95e-06	3.49e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PCK1—obesity	5.94e-06	3.49e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—HADH—obesity	5.94e-06	3.49e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—FADS1—obesity	5.94e-06	3.49e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IGF2—obesity	5.94e-06	3.49e-05	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—ALB—obesity	5.93e-06	3.48e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—FASN—obesity	5.92e-06	3.48e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—RHOA—obesity	5.91e-06	3.47e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—F2—obesity	5.9e-06	3.47e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PRKCB—obesity	5.9e-06	3.47e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—BCHE—obesity	5.89e-06	3.46e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—GNAS—obesity	5.89e-06	3.46e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PIK3R1—obesity	5.85e-06	3.44e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—BAD—obesity	5.83e-06	3.43e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ACP5—obesity	5.78e-06	3.4e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—APOB—obesity	5.77e-06	3.39e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PRKCD—obesity	5.71e-06	3.35e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CYP2E1—obesity	5.69e-06	3.34e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PIK3CG—obesity	5.65e-06	3.32e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—G6PD—obesity	5.64e-06	3.31e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CCL5—obesity	5.63e-06	3.31e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—NQO1—obesity	5.62e-06	3.3e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HTR2A—obesity	5.59e-06	3.28e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IRS1—obesity	5.58e-06	3.28e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—C3—obesity	5.58e-06	3.28e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SREBF2—obesity	5.57e-06	3.27e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—HK1—obesity	5.57e-06	3.27e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—LPL—obesity	5.51e-06	3.23e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—FOXO1—obesity	5.47e-06	3.21e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—RPS6KB1—obesity	5.46e-06	3.2e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PIK3CB—obesity	5.4e-06	3.17e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—SLC2A4—obesity	5.39e-06	3.17e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GCG—obesity	5.39e-06	3.17e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—POMC—obesity	5.38e-06	3.16e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—LPA—obesity	5.38e-06	3.16e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—INS—obesity	5.35e-06	3.14e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CYCS—obesity	5.32e-06	3.12e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IRS2—obesity	5.31e-06	3.12e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—AGT—obesity	5.3e-06	3.11e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CCL2—obesity	5.26e-06	3.09e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—LPIN1—obesity	5.26e-06	3.09e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GOT1—obesity	5.22e-06	3.07e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GGT1—obesity	5.22e-06	3.07e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—APOE—obesity	5.2e-06	3.05e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—LEP—obesity	5.2e-06	3.05e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IGF1—obesity	5.17e-06	3.04e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—AKT2—obesity	5.17e-06	3.04e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—APOA5—obesity	5.15e-06	3.03e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CAV1—obesity	5.15e-06	3.02e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—NCOA1—obesity	5.14e-06	3.02e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—APOA1—obesity	5.14e-06	3.02e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PRKCD—obesity	5.07e-06	2.98e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CYP19A1—obesity	5.07e-06	2.98e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—STK11—obesity	5.07e-06	2.98e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PIK3CD—obesity	4.97e-06	2.92e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HTR2A—obesity	4.96e-06	2.91e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ESR1—obesity	4.96e-06	2.91e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—C3—obesity	4.96e-06	2.91e-05	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—PIK3CA—obesity	4.92e-06	2.89e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CLOCK—obesity	4.92e-06	2.89e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SLC22A1—obesity	4.92e-06	2.89e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—SERPINE1—obesity	4.91e-06	2.88e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PRKCB—obesity	4.9e-06	2.88e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—F2—obesity	4.9e-06	2.88e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—BAD—obesity	4.84e-06	2.84e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SULT2A1—obesity	4.79e-06	2.81e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GLP1R—obesity	4.79e-06	2.81e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TYK2—obesity	4.78e-06	2.81e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—RHOA—obesity	4.74e-06	2.78e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IRS2—obesity	4.72e-06	2.77e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—DPYD—obesity	4.71e-06	2.77e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—COMT—obesity	4.71e-06	2.77e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—AGT—obesity	4.71e-06	2.77e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NOS3—obesity	4.69e-06	2.75e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PIK3R1—obesity	4.69e-06	2.75e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PIK3CG—obesity	4.69e-06	2.75e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GNB3—obesity	4.65e-06	2.73e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PPARGC1A—obesity	4.65e-06	2.73e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IRS1—obesity	4.63e-06	2.72e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—HMOX1—obesity	4.63e-06	2.72e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—LEP—obesity	4.61e-06	2.71e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—APOE—obesity	4.61e-06	2.71e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CAV1—obesity	4.57e-06	2.69e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—APOA1—obesity	4.56e-06	2.68e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PRKAR2B—obesity	4.54e-06	2.66e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GNAS—obesity	4.52e-06	2.66e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—DCN—obesity	4.51e-06	2.65e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—PIK3CA—obesity	4.47e-06	2.62e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—POMC—obesity	4.46e-06	2.62e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—INS—obesity	4.44e-06	2.61e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—APOB—obesity	4.43e-06	2.6e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ESR1—obesity	4.41e-06	2.59e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CPT1A—obesity	4.38e-06	2.57e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CCL2—obesity	4.37e-06	2.56e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PRKCB—obesity	4.35e-06	2.56e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—F2—obesity	4.35e-06	2.56e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PIK3CB—obesity	4.33e-06	2.54e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MTOR—obesity	4.33e-06	2.54e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—BAD—obesity	4.3e-06	2.53e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—NAMPT—obesity	4.3e-06	2.52e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IGF1—obesity	4.29e-06	2.52e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—AKT2—obesity	4.29e-06	2.52e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GCK—obesity	4.27e-06	2.51e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—LIPC—obesity	4.27e-06	2.51e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—APOC3—obesity	4.24e-06	2.49e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—LPL—obesity	4.23e-06	2.48e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PIK3CG—obesity	4.16e-06	2.45e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GPX1—obesity	4.13e-06	2.42e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PIK3CD—obesity	4.12e-06	2.42e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CETP—obesity	4.12e-06	2.42e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IRS1—obesity	4.12e-06	2.42e-05	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—PIK3CA—obesity	4.08e-06	2.4e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—SERPINE1—obesity	4.08e-06	2.39e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SDC1—obesity	4.07e-06	2.39e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CD36—obesity	4.02e-06	2.36e-05	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—AKT1—obesity	4.02e-06	2.36e-05	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PIK3CA—obesity	4.01e-06	2.35e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—AKR1C3—obesity	4.01e-06	2.35e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TYK2—obesity	3.97e-06	2.33e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—POMC—obesity	3.96e-06	2.33e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—IL6—obesity	3.96e-06	2.32e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SCARB1—obesity	3.95e-06	2.32e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—INS—obesity	3.94e-06	2.32e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—RHOA—obesity	3.93e-06	2.31e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PIK3R1—obesity	3.89e-06	2.29e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NOS3—obesity	3.89e-06	2.29e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CCL2—obesity	3.88e-06	2.28e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SREBF1—obesity	3.83e-06	2.25e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IGF1—obesity	3.81e-06	2.24e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—AKT2—obesity	3.81e-06	2.24e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—MTHFR—obesity	3.81e-06	2.24e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MMP9—obesity	3.76e-06	2.21e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PPARA—obesity	3.74e-06	2.19e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GOT2—obesity	3.73e-06	2.19e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—PIK3CA—obesity	3.71e-06	2.18e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PIK3CD—obesity	3.66e-06	2.15e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MAPK8—obesity	3.66e-06	2.15e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—AKT1—obesity	3.65e-06	2.14e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—FASN—obesity	3.65e-06	2.14e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—BCHE—obesity	3.63e-06	2.13e-05	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—PIK3CA—obesity	3.63e-06	2.13e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SERPINE1—obesity	3.62e-06	2.13e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—AGT—obesity	3.62e-06	2.13e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PIK3CB—obesity	3.59e-06	2.11e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MTOR—obesity	3.59e-06	2.11e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—APOE—obesity	3.55e-06	2.08e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TYK2—obesity	3.52e-06	2.07e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CAV1—obesity	3.51e-06	2.06e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—APOA1—obesity	3.51e-06	2.06e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CYP2E1—obesity	3.5e-06	2.06e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—RHOA—obesity	3.49e-06	2.05e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—NQO1—obesity	3.46e-06	2.03e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PIK3R1—obesity	3.46e-06	2.03e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NOS3—obesity	3.46e-06	2.03e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—STAT3—obesity	3.35e-06	1.96e-05	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—AKT1—obesity	3.34e-06	1.96e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GCG—obesity	3.32e-06	1.95e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SLC2A4—obesity	3.32e-06	1.95e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PIK3CA—obesity	3.29e-06	1.93e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—IL6—obesity	3.28e-06	1.93e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CYCS—obesity	3.28e-06	1.93e-05	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—AKT1—obesity	3.28e-06	1.92e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GGT1—obesity	3.22e-06	1.89e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GOT1—obesity	3.22e-06	1.89e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PIK3CG—obesity	3.2e-06	1.88e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PIK3CB—obesity	3.19e-06	1.87e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MTOR—obesity	3.19e-06	1.87e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—NCOA1—obesity	3.17e-06	1.86e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MMP9—obesity	3.12e-06	1.83e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—STK11—obesity	3.12e-06	1.83e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CYP19A1—obesity	3.12e-06	1.83e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MYC—obesity	3.11e-06	1.83e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TGFB1—obesity	3.1e-06	1.82e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PPARG—obesity	3.09e-06	1.81e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—POMC—obesity	3.05e-06	1.79e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MAPK8—obesity	3.04e-06	1.78e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—INS—obesity	3.03e-06	1.78e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—AKT1—obesity	3.03e-06	1.78e-05	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—AKT1—obesity	2.96e-06	1.74e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—IL6—obesity	2.92e-06	1.71e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—COMT—obesity	2.9e-06	1.7e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GNB3—obesity	2.86e-06	1.68e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PPARGC1A—obesity	2.86e-06	1.68e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—HMOX1—obesity	2.85e-06	1.67e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PIK3CD—obesity	2.81e-06	1.65e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GNAS—obesity	2.79e-06	1.64e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ALB—obesity	2.78e-06	1.63e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—STAT3—obesity	2.78e-06	1.63e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MMP9—obesity	2.77e-06	1.63e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—APOB—obesity	2.73e-06	1.6e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MAPK8—obesity	2.7e-06	1.58e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—AKT1—obesity	2.69e-06	1.58e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—NOS3—obesity	2.66e-06	1.56e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PIK3R1—obesity	2.66e-06	1.56e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PIK3CA—obesity	2.64e-06	1.55e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—LPL—obesity	2.61e-06	1.53e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MYC—obesity	2.58e-06	1.52e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TGFB1—obesity	2.57e-06	1.51e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GPX1—obesity	2.54e-06	1.49e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CD36—obesity	2.48e-06	1.45e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—STAT3—obesity	2.47e-06	1.45e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PIK3CB—obesity	2.45e-06	1.44e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PTGS2—obesity	2.43e-06	1.43e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—MTHFR—obesity	2.35e-06	1.38e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—IL6—obesity	2.34e-06	1.37e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PPARA—obesity	2.3e-06	1.35e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MYC—obesity	2.29e-06	1.35e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TGFB1—obesity	2.29e-06	1.34e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—AGT—obesity	2.23e-06	1.31e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PIK3CA—obesity	2.19e-06	1.29e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—APOE—obesity	2.18e-06	1.28e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CAV1—obesity	2.16e-06	1.27e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—APOA1—obesity	2.16e-06	1.27e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—AKT1—obesity	2.16e-06	1.27e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PIK3CG—obesity	1.97e-06	1.16e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PIK3CA—obesity	1.95e-06	1.14e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—IL6—obesity	1.94e-06	1.14e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PPARG—obesity	1.9e-06	1.12e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—POMC—obesity	1.88e-06	1.1e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—INS—obesity	1.87e-06	1.1e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—AKT1—obesity	1.79e-06	1.05e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PIK3CD—obesity	1.73e-06	1.02e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—IL6—obesity	1.72e-06	1.01e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ALB—obesity	1.71e-06	1e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PIK3R1—obesity	1.64e-06	9.61e-06	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—NOS3—obesity	1.64e-06	9.61e-06	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—AKT1—obesity	1.59e-06	9.33e-06	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PIK3CB—obesity	1.51e-06	8.87e-06	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PTGS2—obesity	1.5e-06	8.79e-06	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PIK3CA—obesity	1.49e-06	8.78e-06	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—AKT1—obesity	1.22e-06	7.17e-06	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PIK3CA—obesity	9.21e-07	5.41e-06	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—AKT1—obesity	7.52e-07	4.42e-06	CbGpPWpGaD
